Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    18%
  • Revenue 3 Yr Growth Rank
    87
  • EPS 3 Yr Annual Growth Rate
    73%
  • EPS 3 Yr Growth Rank
    15
  • Total Return 3 Yr Annual Rate
    112%
  • Total Return 3 Yr Rank
    1

Heartworm and digital imaging products have bolstered sales at Heska, a maker of veterinary diagnostic products primarily for dogs and cats.

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Location
Loveland, Colo.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Kevin Wilson
Websitehttp://www.heska.com

Revenue, Net Income

Revenue past four quarters ($M)$133
Net Income past four quarters ($M)$14

Growth Rates and Ranks

Revenue 3 Yr Growth Rank87
Revenue 3 Yr Annual Growth Rate18%
EPS 3 Yr Growth Rank15
EPS 3 Yr Annual Growth Rate73%
Total Return 3 Yr Rank1
Total Return 3 Yr Annual Rate112%
Beat S&P 500 (9.6%)
yes
P/E Ratio57